A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements

Pharmacotherapy

Volumn 17, Issue 5 I, 1997, Pages 861-866

  Bussey, Henry I ^a   Chiquette, Elaine ^a   Bianco, Theresa M ^a   Lowder Bender, Kathryn ^a   Kraynak, Maura A ^a   Linn, William D ^a   Farnett, Lisa ^a   Clark, Gary M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTHROMBIN; WARFARIN;

ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; PROTHROMBIN TIME; RELIABILITY;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; COHORT STUDIES; DECISION MAKING; DIAGNOSTIC TESTS, ROUTINE; EVALUATION STUDIES; HUMANS; PROSPECTIVE STUDIES; PROTHROMBIN TIME; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 0030881260     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fihn S. Aiming for safe anticoagulation. N Engl J Med 1995;333:54-5.
2. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-10.
3. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-7.
4. Becker DM, Humphries JE, Walker FB, et al. Standardizing the prothrombin time: calibrating coagulation instrument as well as thromboplastin. Arch Pathol Lab Med 1993;117:592-602.
5. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152:589-92.
6. Foulis PR, Wallach PM, Adelman HM, et al. Performance of the Coumatrak system in a large anticoagulation clinic. Am J Clin Pathol 1995;103:98-102.
7. Tripodi A, Arbini AA, Chantarangkul V, et al. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thrombosis and Haemostasis 1993;70:921-4.
8. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol 1987;88:442-6.
9. Le DT, Weibert RT, Sevilla BK, et al. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med 1994:120:552-8.
10. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-7.
11. Altman DG, Bland JM. Measurements in medicine: the analysis of method comparison studies. Statistician 1983;32:307-17.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
13. Bland JM, Altman DG. Comparing methods of measurement: why plotting differences against standard method is misleading. Lancet 1995;346:1085-7.
14. Bianco TM, Bussey HI, Farnett L, et al. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy 1992;12:271-2.
15. Bender KN, Kraynak MA, Chiquette E, et al. Effects of marine fish oils on the anticoagulation status of patients on chronic warfarin therapy [abstr]. Pharmacotherapy 1995;15:108.
16. Cunningham MT, Johnson GF, Pennell BJ, Olson JD. The reliability of manufacturer-determined instrument-specific international sensitivity index values for calculating the international normalized ratio. J Clin Pathol 1994;102:128-33.